Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 21

Trial Status

Completed3
Recruiting1

Role Distribution

Other Roles4

Activity Timeline

Clinical Trials (4)

NCT05187832Phase 1Recruiting
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
Advanced or Metastatic Breast Cancer
StudydirectorStart date: 2022-10-05
NCT04712500Phase 1Completed
A Food-Effect Study of AND017 in Healthy Participants
Healthy Volunteers
StudydirectorStart date: 2020-07-30
NCT04751539Phase 1Completed
A Dose-escalation Study of AND017 in Healthy Subjects
Healthy Volunteers
StudydirectorStart date: 2018-07-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Kind Pharmaceuticals LLC

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05187832Phase 1StudyDirector

A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

Advanced or Metastatic Breast Cancer
Recruiting
NCT05035641Phase 2StudyDirector

A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

Renal Anemia
Completed
NCT04712500Phase 1StudyDirector

A Food-Effect Study of AND017 in Healthy Participants

Healthy Volunteers
Completed
NCT04751539Phase 1StudyDirector

A Dose-escalation Study of AND017 in Healthy Subjects

Healthy Volunteers
Completed

All 4 trials loaded